news
Disease recreated in mini-kidney organoids in the lab
23 October 2015 | By Victoria White
The work paves the way for personalised drug discovery for kidney disease...
List view / Grid view
Imaging
news
Gene discovery could lead to new treatments for sepsis
22 October 2015 | By Victoria White
Scientists have isolated the gene that produces Gasdermin-D - a protein that plays a critical role in the pathway to sepsis...
news
Launch of Dementia Discovery Fund to deliver new dementia treatments by 2025
21 October 2015 | By Kate Douetil
This innovative new global investment fund has gained support from a wide variety of investors, including the UK Government’s Department of Health (DoH), Alzheimer’s Research UK and world-leading major pharmaceutical companies Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda...
news
Domainex and ICL team up to discover myocardial infarction therapies
20 October 2015 | By Victoria White
Domainex has been selected as Imperial’s strategic drug discovery partner to provide services including biochemical and biophysical assay development...
news
Nuevolution in drug discovery collaboration with Janssen
19 October 2015 | By Victoria White
Within the framework of the collaboration, Nuevolution will apply its drug discovery platform Chemetics to discover and advance drug candidates...
news
OICR, Novera and Janssen to develop haematological cancer therapies
15 October 2015 | By Victoria White
As part of the collaboration, Novera will discover and develop novel therapeutic compounds identified through OICR's drug discovery programme...
news
GPR3 identified as a new target for Alzheimer’s disease treatment
15 October 2015 | By Victoria White
Researchers have determined that the protein GPR3 might play an important role in alleviating the cognitive deficits of 'amyloid plaques'...
whitepaper
App Note: Easy Particle Analysis for Viscous Samples with MFI
In this application note, learn how the manual MFI 5000 performs accurate particle analysis for viscous protein therapeutics, offering size, count and morphology...
whitepaper
App Note: Achieving 21 CFR Part 11 Compliance with the iCE3
Rapid analysis, platform methods and easy method development make the iCE3 ideal for analyzing biologics...
news
Lilly and ImaginAb to investigate imaging agent in immuno-oncology therapies
13 October 2015 | By Victoria White
ImaginAb will conduct preclinical research using its immune imaging agent, IAB22M2C, to detect T-cell trafficking, redirection and infiltration in response to Lilly oncology molecules...
whitepaper
App Note: Computer-aided Assay Development for Charge Heterogeneity Analysis by iCE
Due to protein therapeutic complexity, techniques like isoelectric focusing have become indispensable tools in evaluating biologic preparations...
news
Astex Pharmaceuticals joins The Dementia Consortium
12 October 2015 | By Victoria White
The Dementia Consortium is a £3.5m drug discovery collaboration between Alzheimer’s Research UK, MRC Technology, Eisai, Lilly and now Astex...
whitepaper
App Note: Fast, Multi-sample Particle Analysis Using MVSS 4.0
Micro-Flow Imaging™ (MFI™) has new MVSS 4.0 software to classify particles across many biopharmaceutical samples easily and instantaneously...
news
Lilly announces New York R&D site expansion
12 October 2015 | By Victoria White
Lilly has announced plans to add 30,000 square feet to its research and development site at the Alexandria Centre for Life Science in New York...
whitepaper
App Note: Comparability Study of Manual and Automated Particle Characterization with MFI
In collaboration with Takeda, Micro-Flow Imaging with the Bot1 Autosampler automated manual methods for monitoring biopharmaceutical quality/safety...
